Food News and Research

RSS

Researchers develop new device with nano-sized features to grab cancer cells

Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor.

19 Nov 2009

U.S. to consider purchasing some food aid locally, acting USAID head says at World Food Summit

The U.S. is interested in potentially using more locally-produced food aid rather than U.S. grown food as a way to expand investment in agricultural development in the developing world, said Alonzo Fulgham, acting head USAID, "on the sidelines of a World Food Summit in Rome" on Tuesday, Reuters reports.

19 Nov 2009

Endologix receives IDE conditional approval from FDA

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has received Investigational Device Exemption (IDE) conditional approval from the United States Food and Drug Administration ("FDA") to begin a prospective, multicenter, randomized clinical trial for a bilateral percutaneous approach to endovascular abdominal aortic aneurysm repair (EVAR) utilizing the Company's IntuiTrak(TM) endovascular delivery system for the Powerlink® family of stent grafts.

19 Nov 2009

Nicardipine Hydrochloride Injection for short-term treatment of hypertension launched

Caraco Pharmaceutical Laboratories, Ltd. has launched Nicardipine Hydrochloride Injection immediately following Sun Pharma's final approval from the US Food and Drug Administration (FDA).

19 Nov 2009

Update on FDA's review of BSD-2000 Hyperthermia System for patients with cervical carcinoma provided

BSD Medical Corporation (www.bsdmedical.com) today provided an update on the U.S. Food and Drug Administration’s (FDA) review of the Company's Humanitarian Device Exemption (HDE) marketing submission for the Company’s BSD-2000 Hyperthermia System.

18 Nov 2009

GTS, the first company to develop and commercialize a unique form of ultrasound technology

Guided Therapy Systems, LLC (GTS), a leading medical technology company, is the first company in the world to develop and commercialize products that employ a unique form of ultrasound technology, Intense Therapeutic Ultrasound (ITU).

18 Nov 2009

Also in Global Health news: Sleeping sickness; aid for Philippines; U.S., China in Africa; polio eradication in Afghanistan; Ethiopia famine

Lancet Infectious Diseases Newsdesk examines how despite evidence that a new therapy to treat sleeping sickness, called nifurtimox—eflornithine (NECT) is a step forward in treating the disease, it has yet to be implemented by countries "13 months after data from a successful trial was presented." The main issue at hand - "nifurtimox is not registered for use in sleeping sickness," the journal writes. The article also examines other factors complicating the implementation of the therapy (Morris, 12/09).

18 Nov 2009

St. Jude Medical announces implantation of the first patient in China with its Eon rechargeable neurostimulator

St. Jude Medical, Inc. announced today that a 62-year-old man from Shenzhen, Guangdong province has become the first patient in China to be implanted with the Eon™ neurostimulator, a rechargeable device used to help manage chronic pain. Despite prior back surgeries, the patient suffered from chronic back pain for more than a decade.

18 Nov 2009

W. L. Gore to distribute QXMédical's Q50 Stent Graft Balloon Catheter

W. L. Gore & Associates today announced it has entered into a partnership with QXMédical, LLC, a medical device development and marketing company. As part of the agreement, Gore will distribute the Q50 Stent Graft Balloon Catheter which is designed for use with aortic stent grafts that treat abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA).

18 Nov 2009

Gene-diet interaction influencing BMI and obesity replicated in three independent studies

Tufts University researchers have identified a gene-diet interaction that appears to influence body weight and have replicated their findings in three independent studies. Men and women carrying the CC genotype demonstrated higher body mass index (BMI) scores and a higher incidence of obesity, but only if they consumed a diet high in saturated fat. These associations were seen in the apolipoprotein A-II gene (APOA2) promoter.

18 Nov 2009

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine

Sinovac Biotech Ltd., a leading developer and provider of vaccines in China, announced today that it received a revised production license from State Food and Drug Administration for Panflu.1, the Company's H1N1 vaccine. The population has been expanded to include people over 60 years old. The shelf life for PANFLU.1 was extended to one year from six months.

18 Nov 2009

Positive results from REVIVE, a phase 3 pivotal study of avanafil announced

VIVUS, Inc. today announced positive results from REVIVE (TA-301), a phase 3 pivotal study evaluating the safety and efficacy of avanafil, an investigational drug candidate for the treatment of erectile dysfunction (ED), in 646 patients.

18 Nov 2009

Childhood obesity in Ohio: Healthy Choices for Healthy Children legislation introduced

A bi-partisan effort to decrease and prevent childhood obesity was introduced today in the Ohio Senate and Ohio House of Representatives, with the strong support of the Healthy Choices for Healthy Children coalition. The Healthy Choices for Healthy Children legislation is co-sponsored by Senator Kevin Coughlin (R-Cuyahoga Falls) and Senator Eric H. Kearney (D-Cincinnati) in the Ohio Senate.

18 Nov 2009

Request for pre-IND meeting to discuss IND application for therapeutic vaccine granted by FDA

GeoVax Labs, Inc. (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that the U.S. Food and Drug Administration (FDA) has granted its request for a pre-IND meeting to discuss the proposed Investigational New Drug (IND) application for GeoVax's therapeutic vaccine as a treatment for individuals already infected with HIV.

18 Nov 2009

Chembio Diagnostics to present possibilities of OTC home-use HIV test kits at the FDA meeting

Chembio Diagnostics, Inc., a company that develops, manufactures, licenses, and markets proprietary rapid diagnostic tests, announced today that it will present at a meeting of the Blood Products Advisory Committee ("BPAC") of the U.S. Food and Drug Administration ("FDA") in Bethesda, Maryland, on the afternoon of November 17, 2009.

18 Nov 2009

Ambrisentan improves health and exercise capacity of PAH patients, find researchers

In one of the few studies of the long-term effects of medication in the treatment of pulmonary arterial hypertension (PAH) disease, a team of researchers found the health and exercise capacity of PAH patients improved after two years of treatment with ambrisentan, according to a study published in the current edition of the Journal of the American College of Cardiology.

18 Nov 2009

Updated clinical data from Poniard Pharmaceuticals' picoplatin Phase 2 trial announced

Poniard Pharmaceuticals, Inc. today announced updated clinical data from its randomized, controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC).

18 Nov 2009

Verax Platelet PGD test receives FDA clearance

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has cleared the Verax Platelet PGD® test as a quality control test to detect bacterial contamination in whole blood-derived, pooled platelets prior to transfusion. Fenwal is the exclusive global distributor of the test, which was developed by Verax Biomedical of Worcester, Mass.

18 Nov 2009

New Drug Application for NicOx's naproxcinod accepted for filing

NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.

18 Nov 2009

Quest Diagnostics' Simplexa Influenza A H1N1 (2009) test receives CE mark

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa Influenza A H1N1 (2009) test developed by its Focus Diagnostics business has been CE marked and is now available as a test kit for distribution to approximately 35 countries in Europe.

From Quest Diagnostics 18 Nov 2009

Food News and Research

Researchers develop new device with nano-sized features to grab cancer cells

U.S. to consider purchasing some food aid locally, acting USAID head says at World Food Summit

Endologix receives IDE conditional approval from FDA

Nicardipine Hydrochloride Injection for short-term treatment of hypertension launched

Update on FDA's review of BSD-2000 Hyperthermia System for patients with cervical carcinoma provided

GTS, the first company to develop and commercialize a unique form of ultrasound technology

Also in Global Health news: Sleeping sickness; aid for Philippines; U.S., China in Africa; polio eradication in Afghanistan; Ethiopia famine

St. Jude Medical announces implantation of the first patient in China with its Eon rechargeable neurostimulator

W. L. Gore to distribute QXMédical's Q50 Stent Graft Balloon Catheter

Gene-diet interaction influencing BMI and obesity replicated in three independent studies

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine

Positive results from REVIVE, a phase 3 pivotal study of avanafil announced

Childhood obesity in Ohio: Healthy Choices for Healthy Children legislation introduced

Request for pre-IND meeting to discuss IND application for therapeutic vaccine granted by FDA

Chembio Diagnostics to present possibilities of OTC home-use HIV test kits at the FDA meeting

Ambrisentan improves health and exercise capacity of PAH patients, find researchers

Updated clinical data from Poniard Pharmaceuticals' picoplatin Phase 2 trial announced

Verax Platelet PGD test receives FDA clearance

New Drug Application for NicOx's naproxcinod accepted for filing

Quest Diagnostics' Simplexa Influenza A H1N1 (2009) test receives CE mark

The future is bioengineered: Synthetic biology and global sustainability eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News